Private health insurers can open a new health insurance product at any time, at any premium, without the Health Minister’s approval. This Impact Analysis considers a preferred policy approach requiring insurers to seek the Minister’s approval for premiums for new products, and existing products for which cover or value to consumers has been reduced.

Highly concentrated markets can be less competitive, leading to higher prices for consumers. Australia’s two largest supermarket chains account for around two-thirds of supermarket sales. This, combined with recent food price increases, has created renewed interest in how supermarket prices and supplier relationships are regulated. This paper outlines the context and current regulatory mechanisms.

This report details an inquiry investigating the role of Australia's 'big box' retailers and large format retailers in price setting. The inquiry received 19 submissions but was unable to hold public hearings before the 2025 Federal election was called and has therefore made no findings or recommendations.

This report discusses the potential for the Trump administration to ask Australia to water down the Pharmaceutical Benefits Scheme (PBS). This would result in higher medicine prices. The report argues that policies delivering cheaper medicine for Australians should not be considered trade restrictions.

This final report addresses key issues identified in the Supermarkets Inquiry interim report, and analysed during the second phase of the inquiry. The report finds Coles and Woolworths dominate the Australian grocery sector and this is set to continue; and presents recommendations to the government.